Skip to main content
SpringerLink
Log in

Ketoconazole in advanced prostate cancer: have tolerability concerns been overstated?

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8–30

    Article  PubMed  CAS  Google Scholar 

  2. Cersosimo RJ, Carr D. Prostate cancer: current and evolving strategies. Am J Health-Syst Pharm 1996; 53: 381–96

    PubMed  CAS  Google Scholar 

  3. Bok RA, Small EJ. The treatment of advanced prostate cancer with ketoconazole.

  4. Amery WK, De Coster R, Caers I. Ketoconazole: from an antimycotic to a drug for prostate cancer. Drug Dev Res 1986; 8: 299–307

    Article  Google Scholar 

  5. Trachtenberg J, Pont A. Ketoconazole therapy for advanced prostate cancer. Lancet 1984; II(8400): 433–5

    Article  Google Scholar 

  6. Small EJ, Baron AD, Fippin L, et al. Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal. J Urol 1997; 157: 1204–7

    Article  PubMed  CAS  Google Scholar 

  7. British National Formulary. No. 38. London: The Pharmaceutical Press, 1999 Sep: 280, 570-1

  8. Small EJ, Baron A, Bok R. Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma. cancer 1997; 80: 1755–9

    Article  PubMed  CAS  Google Scholar 

  9. De Coster R, Wouters W, Bruynseels J. P450-dependent enzymes as targets for prostate cancer therapy. J Steroid Biochem Mol Biol 1996; 56 (1–6 Spec. No.): 133–43

    Article  PubMed  Google Scholar 

  10. Sarver RG, Dalkin BL, Ahmann FR. Ketoconazole-induced adrenal crisis in a patient with metastatic prostate adenocarcinoma: case report and review of the literature. Urology 1997; 49: 781–5

    Article  PubMed  CAS  Google Scholar 

  11. Rodriguez RJ, Acosta Jr D. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology 1997; 117: 123–31

    Article  PubMed  CAS  Google Scholar 

  12. Iake-Bakaar G, Scheuer PJ, Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom. BMJ (Clin Res Ed.) 1987; 294(6569): 419–22

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ketoconazole in advanced prostate cancer: have tolerability concerns been overstated?. Drugs Ther. Perspect 15, 11–13 (2000). https://doi.org/10.2165/00042310-200015040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015040-00004

Keywords

Search

Navigation